{"id":"https://openalex.org/W2034425055","doi":"https://doi.org/10.2165/0003088-200948010-00003","title":"Lack of Pharmacokinetic Interaction of Mipomersen Sodium (ISIS 301012), a 2\u2032-O-Methoxyethyl Modified Antisense Oligonucleotide Targeting Apolipoprotein B-100 Messenger RNA, with Simvastatin and Ezetimibe","display_name":"Lack of Pharmacokinetic Interaction of Mipomersen Sodium (ISIS 301012), a 2\u2032-O-Methoxyethyl Modified Antisense Oligonucleotide Targeting Apolipoprotein B-100 Messenger RNA, with Simvastatin and Ezetimibe","publication_year":2008,"publication_date":"2008-12-11","ids":{"openalex":"https://openalex.org/W2034425055","doi":"https://doi.org/10.2165/0003088-200948010-00003","mag":"2034425055","pmid":"https://pubmed.ncbi.nlm.nih.gov/19071883"},"language":"en","primary_location":{"id":"doi:10.2165/0003088-200948010-00003","doi":"https://doi.org/10.2165/0003088-200948010-00003","is_oa":false,"landing_page_url":"https://doi.org/10.2165/0003088-200948010-00003","pdf_url":null,"source":{"id":"https://openalex.org/S69290020","display_name":"Clinical Pharmacokinetics","issn_l":"0312-5963","issn":["0312-5963","1179-1926"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacokinetics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5002446366","display_name":"Rosie Z. Yu","orcid":"https://orcid.org/0000-0001-9266-7280","observed_orcids":["https://orcid.org/0000-0001-9266-7280"]},"institutions":[{"id":"https://openalex.org/I2800035258","display_name":"Ionis Pharmaceuticals (United States)","ror":"https://ror.org/00t8bew53","country_code":"US","type":"company","lineage":["https://openalex.org/I2800035258"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Rosie Z Yu","raw_affiliation_strings":["Isis Pharmaceuticals, Inc., Carlsbad, California 92008, USA. ryu@isisph","Isis Pharmaceuticals, Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Isis Pharmaceuticals, Inc., Carlsbad, California 92008, USA. ryu@isisph","institution_ids":["https://openalex.org/I2800035258"]},{"raw_affiliation_string":"Isis Pharmaceuticals, Inc","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056554811","display_name":"Richard S. Geary","orcid":"https://orcid.org/0000-0002-6308-3179","observed_orcids":["https://orcid.org/0000-0002-6308-3179"]},"institutions":[{"id":"https://openalex.org/I2800035258","display_name":"Ionis Pharmaceuticals (United States)","ror":"https://ror.org/00t8bew53","country_code":"US","type":"company","lineage":["https://openalex.org/I2800035258"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard S Geary","raw_affiliation_strings":["Isis Pharmaceuticals, Inc., 1896 Rutherford Road, Carlsbad, California, 92008, USA","Isis Pharmaceuticals, Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Isis Pharmaceuticals, Inc., 1896 Rutherford Road, Carlsbad, California, 92008, USA","institution_ids":["https://openalex.org/I2800035258"]},{"raw_affiliation_string":"Isis Pharmaceuticals, Inc","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038516108","display_name":"JoAnn Flaim","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800035258","display_name":"Ionis Pharmaceuticals (United States)","ror":"https://ror.org/00t8bew53","country_code":"US","type":"company","lineage":["https://openalex.org/I2800035258"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"JoAnn D Flaim","raw_affiliation_strings":["Isis Pharmaceuticals, Inc., 1896 Rutherford Road, Carlsbad, California, 92008, USA","Isis Pharmaceuticals, Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Isis Pharmaceuticals, Inc., 1896 Rutherford Road, Carlsbad, California, 92008, USA","institution_ids":["https://openalex.org/I2800035258"]},{"raw_affiliation_string":"Isis Pharmaceuticals, Inc","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009668292","display_name":"Gina C Riley","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800035258","display_name":"Ionis Pharmaceuticals (United States)","ror":"https://ror.org/00t8bew53","country_code":"US","type":"company","lineage":["https://openalex.org/I2800035258"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gina C Riley","raw_affiliation_strings":["Isis Pharmaceuticals, Inc., 1896 Rutherford Road, Carlsbad, California, 92008, USA","Isis Pharmaceuticals, Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Isis Pharmaceuticals, Inc., 1896 Rutherford Road, Carlsbad, California, 92008, USA","institution_ids":["https://openalex.org/I2800035258"]},{"raw_affiliation_string":"Isis Pharmaceuticals, Inc","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112518216","display_name":"Diane L. Tribble","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800035258","display_name":"Ionis Pharmaceuticals (United States)","ror":"https://ror.org/00t8bew53","country_code":"US","type":"company","lineage":["https://openalex.org/I2800035258"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Diane L Tribble","raw_affiliation_strings":["Isis Pharmaceuticals, Inc., 1896 Rutherford Road, Carlsbad, California, 92008, USA","Isis Pharmaceuticals, Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Isis Pharmaceuticals, Inc., 1896 Rutherford Road, Carlsbad, California, 92008, USA","institution_ids":["https://openalex.org/I2800035258"]},{"raw_affiliation_string":"Isis Pharmaceuticals, Inc","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111777135","display_name":"Andr A vanVliet","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andr\u00e9 A vanVliet","raw_affiliation_strings":["Pharma Bio-Research Group BV, Zuidlaren, The Netherlands","Pharma Bio-Research Group BV"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharma Bio-Research Group BV, Zuidlaren, The Netherlands","institution_ids":[]},{"raw_affiliation_string":"Pharma Bio-Research Group BV","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111818669","display_name":"Mark K. Wedel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800035258","display_name":"Ionis Pharmaceuticals (United States)","ror":"https://ror.org/00t8bew53","country_code":"US","type":"company","lineage":["https://openalex.org/I2800035258"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark K Wedel","raw_affiliation_strings":["Isis Pharmaceuticals, Inc., 1896 Rutherford Road, Carlsbad, California, 92008, USA","Isis Pharmaceuticals, Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Isis Pharmaceuticals, Inc., 1896 Rutherford Road, Carlsbad, California, 92008, USA","institution_ids":["https://openalex.org/I2800035258"]},{"raw_affiliation_string":"Isis Pharmaceuticals, Inc","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5002446366"],"corresponding_institution_ids":["https://openalex.org/I2800035258"],"apc_list":{"value":4990,"currency":"USD","value_usd":4990},"apc_paid":null,"fwci":4.946,"has_fulltext":false,"cited_by_count":102,"citation_normalized_percentile":{"value":0.95505059,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":91,"max":99},"biblio":{"volume":"48","issue":"1","first_page":"39","last_page":"50"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.926800012588501,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.926800012588501,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.052799999713897705,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13430","display_name":"Lipid metabolism and disorders","score":0.0044999998062849045,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/apolipoprotein-b-100","display_name":"apolipoprotein B-100","score":0.8849999904632568},{"id":"https://openalex.org/keywords/antisense-oligonucleotides","display_name":"antisense oligonucleotides","score":0.9629999995231628},{"id":"https://openalex.org/keywords/simvastatin","display_name":"simvastatin","score":0.9129999876022339},{"id":"https://openalex.org/keywords/ezetimibe","display_name":"ezetimibe","score":1.0},{"id":"https://openalex.org/keywords/pharmacokinetic-interactions","display_name":"pharmacokinetic interactions","score":0.7950000166893005},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.8920000195503235},{"id":"https://openalex.org/keywords/cytochrome-p450-inhibition","display_name":"cytochrome P450 inhibition","score":0.9129999876022339},{"id":"https://openalex.org/keywords/cyp3a4","display_name":"CYP3A4","score":0.9380000233650208},{"id":"https://openalex.org/keywords/cyp2c19","display_name":"CYP2C19","score":0.7860000133514404},{"id":"https://openalex.org/keywords/cyp2c9","display_name":"CYP2C9","score":0.8180000185966492},{"id":"https://openalex.org/keywords/cyp2d6","display_name":"CYP2D6","score":0.9100000262260437},{"id":"https://openalex.org/keywords/cyp1a2","display_name":"CYP1A2","score":0.9700000286102295},{"id":"https://openalex.org/keywords/hypercholesterolemia","display_name":"hypercholesterolemia","score":0.8069999814033508},{"id":"https://openalex.org/keywords/lipid-lowering-therapy","display_name":"lipid-lowering therapy","score":0.9150000214576721}],"concepts":[{"id":"https://openalex.org/C2778657065","wikidata":"https://www.wikidata.org/wiki/Q417997","display_name":"Ezetimibe","level":3,"score":0.8330280780792236},{"id":"https://openalex.org/C2776329913","wikidata":"https://www.wikidata.org/wiki/Q670131","display_name":"Simvastatin","level":2,"score":0.697127103805542},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6932659149169922},{"id":"https://openalex.org/C62746215","wikidata":"https://www.wikidata.org/wiki/Q14890615","display_name":"Apolipoprotein B","level":3,"score":0.6336588859558105},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.48467376828193665},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.4723150432109833},{"id":"https://openalex.org/C2780072125","wikidata":"https://www.wikidata.org/wiki/Q28350","display_name":"Lipoprotein","level":3,"score":0.44504687190055847},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.43544384837150574},{"id":"https://openalex.org/C8243546","wikidata":"https://www.wikidata.org/wiki/Q419074","display_name":"Very low-density lipoprotein","level":4,"score":0.4323646128177643},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4318867325782776},{"id":"https://openalex.org/C2776839432","wikidata":"https://www.wikidata.org/wiki/Q954845","display_name":"Statin","level":2,"score":0.38380730152130127},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3573184907436371},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.25395622849464417}],"mesh":[{"descriptor_ui":"D000069438","descriptor_name":"Ezetimibe","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000924","descriptor_name":"Anticholesteremic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D001384","descriptor_name":"Azetidines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009841","descriptor_name":"Oligonucleotides","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019821","descriptor_name":"Simvastatin","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D065607","descriptor_name":"Cytochrome P-450 Enzyme Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.2165/0003088-200948010-00003","doi":"https://doi.org/10.2165/0003088-200948010-00003","is_oa":false,"landing_page_url":"https://doi.org/10.2165/0003088-200948010-00003","pdf_url":null,"source":{"id":"https://openalex.org/S69290020","display_name":"Clinical Pharmacokinetics","issn_l":"0312-5963","issn":["0312-5963","1179-1926"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacokinetics","raw_type":"journal-article"},{"id":"pmid:19071883","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19071883","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical pharmacokinetics","raw_type":"Clinical Trial, Phase I"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":30,"referenced_works":["https://openalex.org/W1496645167","https://openalex.org/W1515542254","https://openalex.org/W1851111672","https://openalex.org/W1961577685","https://openalex.org/W1978419002","https://openalex.org/W1992084132","https://openalex.org/W1996678268","https://openalex.org/W2024858641","https://openalex.org/W2029005246","https://openalex.org/W2032810973","https://openalex.org/W2036914011","https://openalex.org/W2045054080","https://openalex.org/W2053536280","https://openalex.org/W2062230123","https://openalex.org/W2066394912","https://openalex.org/W2072828565","https://openalex.org/W2074472724","https://openalex.org/W2074547063","https://openalex.org/W2077732105","https://openalex.org/W2078350162","https://openalex.org/W2083420496","https://openalex.org/W2104954969","https://openalex.org/W2143228863","https://openalex.org/W2145073911","https://openalex.org/W2147730379","https://openalex.org/W2157668743","https://openalex.org/W2161599977","https://openalex.org/W2255911290","https://openalex.org/W2399825601","https://openalex.org/W2405887519"],"related_works":["https://openalex.org/W1738068946","https://openalex.org/W2037208413","https://openalex.org/W1993796296","https://openalex.org/W1989631351","https://openalex.org/W2345835289","https://openalex.org/W2136292351","https://openalex.org/W140217583","https://openalex.org/W7096589227","https://openalex.org/W2097979418","https://openalex.org/W2399905977"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":7},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":7},{"year":2014,"cited_by_count":10},{"year":2013,"cited_by_count":12},{"year":2012,"cited_by_count":11}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}